Not enough buy signals with a settled T+90 horizon to measure a track record yet.
Discover the complete record of transactions filed by von Moltke Lisa. Director active across 2 companies, notably Cara Therapeutics, Inc.. Cumulatively, 9 disclosures have been logged. Activity tracked since 1 June 2023. The latest transaction was disclosed on 27 October 2024 (Levée d'options). Regulator: SEC (Form 4). The full history is openly available.
Open company profiles for insider transactions, fundamentals and analyst consensus when available.
9 of 9 declarations
Lisa von Moltke is an insider linked to Seres Therapeutics, Inc. and a Director at Cara Therapeutics, Inc. She has 9 filings in total, and the recent filings covered run from 2023-06-05 to 2025-02-19, with option exercises as the modal transaction nature.